The increased level of F11R/JAM-A transcription is notified in breast cancer (Fig. 1B) and is especially apparent in TNBC (Fig. 1C), being a hallmark of poor prognosis due to decreased survival rate (Fig. 1D). This evidence concerns the gene F11R and breast cancer.